Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Amy L. Phillips"'
Autor:
Barry Hendin, Richard A. Brook, Ian A. Beren, Nathan Kleinman, Cindy Fink, Amy L. Phillips, Carroline Lobo
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 10, Iss 1 (2023)
**Background:** Research on employee care partners of patients with multiple sclerosis (MS) is limited. **Objectives:** The clinical and economic impact on employee care partners was evaluated by MS disease severity. **Methods:** Employees with spous
Externí odkaz:
https://doaj.org/article/56026b792be842d882d185ed142dd179
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 9, Iss 2 (2022)
**Background:** Comorbidities are common in patients with multiple sclerosis (MS), thus increasing the complexity of disease management and economic burden and worsening their prognosis and quality of life. Real-world evidence comparing comorbidities
Externí odkaz:
https://doaj.org/article/ea8401075ba04288887af9815082a7db
Autor:
Jacqueline A. Nicholas, Natalie C. Edwards, Roger A. Edwards, Anna Dellarole, Megan Grosso, Amy L. Phillips
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Nonadherence to disease-modifying drugs (DMDs) for multiple sclerosis (MS) is associated with poorer clinical outcomes, including higher rates of relapse and disease progression, and higher medical resource use. A systematic revie
Externí odkaz:
https://doaj.org/article/e060a9371fc14f16bcd4e21da4d3d463
Autor:
Michael B Wohlfeiler, Rachel P Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Amy L Phillips, Brooke Hayward, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco
Publikováno v:
Open Forum Infectious Diseases. 9
Background HIV-associated wasting (i.e., progressive, involuntary weight loss with both fat and lean tissue loss; HIVAW) is an under-appreciated AIDS-defining illness; the 2012-2018 period prevalence was reported as 18% in a recent claims study in th
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Administrative healthcare claims data provide a mechanism for assessing and monitoring multiple sclerosis (MS) disease status across large, clinically representative “real-world” populations. The estimation of MS disease statu
Externí odkaz:
https://doaj.org/article/e6f1a62f35fc42eb90a9847dcfa48dd5
Autor:
Michael Harbour, Javeed Siddiqui, Shanti K. Samuel, Brooke Hayward, Kathleen L. Deering, Amy L. Phillips, Kelly Athayde Wirka, Qing Harshaw
Publikováno v:
AIDS (London, England)
Objective: To understand the prevalence of HIV-associated wasting (HIVAW) in the United States. Design: Medical and pharmacy claims study using IBM MarketScan Commercial, Medicare Supplemental and Medicaid Databases. Methods: Study period: July 2012
Autor:
Ian A Beren, Amy L. Phillips, Carrie M. Hersh, Richard A. Brook, Nicholas J. Rohrbacker, Christian Henke, Lori A Lebson
Publikováno v:
Journal of medical economics. 24(1)
Multiple sclerosis (MS) poses a substantial employer burden in medically related absenteeism and disability costs due to the chronic and debilitating nature of the disease. Although previous studies have evaluated relapse, nonadherence, discontinuati
Autor:
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, Anna Dellarole, Luigi Manca, Danielle E Harlow, Amy L Phillips
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical. 8(2)
Background Increased understanding of adherence may facilitate optimal targeting of interventions. Objective To utilize group-based trajectory modeling (GBTM) to understand longitudinal patterns of adherence and factors associated with non-adherence
Publikováno v:
Multiple sclerosis and related disorders. 46
Real-world data regarding live birth rates (LBRs) and infertility in women with multiple sclerosis (MS) are lacking. This study compared LBRs, infertility diagnoses, and infertility treatments in women with and without MS.Using a retrospective US adm
Publikováno v:
Neurology. 91:e1559-e1569
ObjectiveTo compare pregnancy prevalence and complications in women with and without multiple sclerosis (MS).MethodsThis retrospective US administrative claims study used data from January 1, 2006, to June 30, 2015. All data for women with MS were in